You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • SAT0145 Timing and magnitude of initial response to certolizumab pegol in a broad population of patients with active rheumatoid arthritis predicts likelihood of LDA at week 28

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Posters
Rheumatoid arthritis – anti-TNF therapy
SAT0145 Timing and magnitude of initial response to certolizumab pegol in a broad population of patients with active rheumatoid arthritis predicts likelihood of LDA at week 28

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 2014600
Mar 20141402
Apr 20141801
May 2014301
Jun 2014301
Jul 2014201
Sep 2014100
Oct 2014101
Nov 2014100
Jan 2015200
Feb 2015200
Apr 2015200
May 2015200
Jul 2015200
Aug 2015100
Sep 2015200
Nov 20152401
Feb 2016300
Apr 2016500
May 2016300
Jun 2016200
Jul 2016400
Aug 2016300
Sep 2016200
Oct 2016600
Nov 2016200
Dec 2016301
Jan 2017600
Feb 2017800
Mar 2017600
Apr 2017300
May 2017700
Jun 2017800
Jul 2017600
Aug 2017800
Sep 2017200
Oct 2017600
Nov 2017200
Dec 2017600
Jan 2018600
Feb 2018600
Mar 20181001
Apr 2018600
May 2018800
Jun 2018400
Jul 2018600
Aug 2018800
Sep 2018200
Oct 2018400
Nov 2018400
Dec 2018400
Jan 2019200
Feb 2019600
Apr 2019200
Jun 2019600
Jul 2019400
Aug 2019700
Dec 2019200
Feb 2020200
Jun 2020400
Jul 2020600
Aug 2020400
Sep 20201301
Oct 2020200
Nov 2020400
Dec 2020402
Jan 2021200
Apr 2021700
Jun 2021300
Oct 2021700
Nov 2021201
Dec 2021600
Feb 2022200
Mar 2022200
Apr 2022200
May 20221000
Jun 2022200
Jul 20221600
Aug 2022800
Sep 2022400
Oct 2022400
Nov 2022600
Dec 20221001
Jan 2023400
Feb 2023600
Mar 2023400
May 2023200
Jun 2023100
Jul 2023400
Sep 2023800
Nov 2023400
Dec 2023600
Jan 2024200
Feb 2024200
Mar 2024200
Total461015